What are the types of anti-arrhythmia agents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025 • View editorial policy

From the Guidelines

Anti-arrhythmia agents can be classified into four main types:

  • Type I: Fast sodium channel blockers, which include IA (e.g., Disopyramide, Procainamide, Quinidine), IB (e.g., Lidocaine, Mexiletine), and IC (e.g., Flecainide, Propafenone)
  • Type II: Beta blockers (e.g., Beta-blockers like propranolol)
  • Type III: Repolarization potassium current blockers (e.g., Amiodarone, Sotalol, Dofetilide)
  • Type IV: Calcium channel antagonists (e.g., Verapamil, Diltiazem) 1, 2, 3

Key Characteristics of Each Type

  • Type I: Subclassified into IA, IB, and IC, with different effects on cardiac conduction and contraction
  • Type II: Beta blockers, which reduce sympathetic tone and slow heart rate
  • Type III: Prolong repolarization, increasing the risk of torsades de pointes
  • Type IV: Calcium channel blockers, which reduce calcium influx and slow heart rate

Clinical Use

  • The choice of anti-arrhythmia agent depends on the underlying heart disease, the type of arrhythmia, and the patient's symptoms and medical history 4, 5
  • Each type of anti-arrhythmia agent has its own set of indications, contraindications, and potential side effects, which must be carefully considered in clinical practice 1

From the Research

Types of Anti-Arrhythmia Agents

The types of anti-arrhythmia agents can be classified into four main classes according to the Vaughan Williams classification, which is based on their effects on various ion channels [ 6, 7, 8, 9 ]. These classes are:

  • Class I: Antiarrhythmic agents that block the fast-inward sodium channel on myocardium, including subclassifications such as Class Ia, Class Ib, and Class Ic [ 6, 7, 8, 9 ].
  • Class II: Antisympathetic drugs, particularly the b-adrenoceptor blockers, which are generally safe agents [ 6, 7 ].
  • Class III: Antiarrhythmic agents that prolong action potential duration and repolarization, including drugs such as amiodarone and sotalol [ 6, 7, 8, 9 ].
  • Class IV: Calcium channel blockers, including verapamil and diltiazem, which are normally monitored by haemodynamic effects [ 6, 7 ].

Other Anti-Arrhythmia Agents

In addition to the four main classes, there are other anti-arrhythmia agents that do not fall neatly into the Vaughan Williams classification, including:

  • Digoxin: A drug with unique antiarrhythmic properties, which can be useful in the management of selected patients [ 6, 7 ].
  • Adenosine: A drug with unique antiarrhythmic properties, which can be useful in the management of selected patients [ 7 ].
  • Perhexiline: A drug that can be useful for monitoring the administration and safety of antiarrhythmic agents [ 6 ].

References

Research

Therapeutic drug monitoring: antiarrhythmic drugs.

British journal of clinical pharmacology, 2001

Research

Antiarrhythmic agents and proarrhythmia.

Critical care medicine, 2000

Research

[Current classification of anti-arrhythmia agents].

Zeitschrift fur Kardiologie, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.